BR102020023578A8 - Composições e métodos para tratamento do olho - Google Patents

Composições e métodos para tratamento do olho

Info

Publication number
BR102020023578A8
BR102020023578A8 BR102020023578A BR102020023578A BR102020023578A8 BR 102020023578 A8 BR102020023578 A8 BR 102020023578A8 BR 102020023578 A BR102020023578 A BR 102020023578A BR 102020023578 A BR102020023578 A BR 102020023578A BR 102020023578 A8 BR102020023578 A8 BR 102020023578A8
Authority
BR
Brazil
Prior art keywords
compositions
methods
eye treatment
eye
treatment
Prior art date
Application number
BR102020023578A
Other languages
English (en)
Other versions
BR102020023578A2 (pt
Inventor
Ting Li Wen-Hwa
Mahmood Khalid
Parsa Ramine
Bai Mingqi
T Holeva Kenneth
Original Assignee
Johnson & Johnson Consumer Inc
Johnson & Johnson Surgical Vision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Inc, Johnson & Johnson Surgical Vision Inc filed Critical Johnson & Johnson Consumer Inc
Publication of BR102020023578A2 publication Critical patent/BR102020023578A2/pt
Publication of BR102020023578A8 publication Critical patent/BR102020023578A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/38—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
    • C07C57/40—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic containing condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/33—Polycyclic acids
    • C07C63/49—Polycyclic acids containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

COMPOSIÇÕES E MÉTODOS PARA TRATAMENTO DO OLHO. A presente invenção refere-se a composições que compreendem um ou mais extratos e/ou compostos que têm atividade e propriedades semelhantes ao retinol e a métodos de uso das composições para tratar o olho.
BR102020023578A 2019-11-19 2020-11-18 Composições e métodos para tratamento do olho BR102020023578A8 (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201962937450P 2019-11-19 2019-11-19
US201962937467P 2019-11-19 2019-11-19
US62/937,450 2019-11-19
US62/937,467 2019-11-19
US17/099,166 US11969454B2 (en) 2019-11-19 2020-11-16 Compositions and methods for treating the eye
US17/099,166 2020-11-16

Publications (2)

Publication Number Publication Date
BR102020023578A2 BR102020023578A2 (pt) 2021-05-25
BR102020023578A8 true BR102020023578A8 (pt) 2023-02-07

Family

ID=75966189

Family Applications (1)

Application Number Title Priority Date Filing Date
BR102020023578A BR102020023578A8 (pt) 2019-11-19 2020-11-18 Composições e métodos para tratamento do olho

Country Status (7)

Country Link
US (1) US11969454B2 (pt)
JP (1) JP2021080254A (pt)
KR (1) KR20210061299A (pt)
AU (2) AU2020273325A1 (pt)
BR (1) BR102020023578A8 (pt)
CA (1) CA3099504A1 (pt)
ZA (1) ZA202007183B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210038636A (ko) 2018-07-27 2021-04-07 존슨 앤드 존슨 서지컬 비전, 인코포레이티드 눈 치료용 조성물 및 방법
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye

Family Cites Families (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77254A1 (pt) 1977-05-04 1979-01-18
US4691820A (en) 1985-11-18 1987-09-08 Vistakon, Inc. Package for hydrophilic contact lens
DE3738406A1 (de) 1987-11-12 1989-05-24 Henkel Kgaa Sebosuppressive topische zubereitungen
FR2628632B1 (fr) 1988-03-18 1992-04-03 Gattefosse Ets Sa Microemulsions a usage cosmetique ou pharmaceutique
DK0579830T3 (da) 1990-11-13 1997-08-18 Santen Pharmaceutical Co Ltd Terapeutisk middel til hornhindebeskadigelse
NZ250453A (en) 1992-12-21 1996-12-20 Johnson & Johnson Vision Prod Ophthalmic lens package; planar surface with concave bowl for containing lens, sealing sheet covering bowl with lens therein
US5578312A (en) 1993-05-05 1996-11-26 Parrinello; Vincene M. Skin care system and method for improving moisture retention in skin
US5823327A (en) 1993-11-02 1998-10-20 Johnson & Johnson Vision Products, Inc. Packaging arrangement for contact lenses
US5577367A (en) 1994-06-10 1996-11-26 Johnson & Johnson Vision Products, Inc. Apparatus and method for sterilization and secondary packaging
US5488815A (en) 1994-06-10 1996-02-06 Johnson & Johnson Vision Products, Inc. Apparatus and method for sterilization and secondary packaging
US5696686A (en) 1994-06-10 1997-12-09 Johnson & Johnson Vision Products, Inc. Computer system for quality control correlations
GB9421613D0 (en) 1994-10-26 1994-12-14 Sandoz Ltd Organic compounds
JPH08133967A (ja) 1994-11-02 1996-05-28 Eisai Co Ltd ドライアイ治療剤
FR2733908B1 (fr) 1995-05-12 1997-06-27 Serobiologiques Lab Sa Utilisation d'extraits de graines de cassia et/ou de trigonelle enrichis en galactomannanes et produit cosmetique ou pharmaceutique, notamment dermatologique, contenant de tels extraits
GB9515214D0 (en) 1995-07-25 1995-09-20 Univ Strathclyde Plant extracts
US5704468A (en) 1995-09-29 1998-01-06 Johnson & Johnson Vision Products, Inc. Packaging arrangement for contact lenses
JPH09268118A (ja) 1996-04-01 1997-10-14 Kao Corp 肌色改善美容剤
DE69730476T2 (de) 1996-04-19 2005-11-17 Tsubota, Kazuo, Funabashi Albumin als aktiver Bestandteil zur Behandlung von Bindehaut- und Hornhautverletzungen und von trockenen Augen
US5847003A (en) 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions
RO115698B1 (ro) 1997-05-09 2002-03-29 Biotehnos S.A. Produse topice de uz uman şi/sau veterinar şi procedeu de obţinere
US6018931A (en) 1998-09-08 2000-02-01 Johnson & Johnson Vision Products, Inc. Method and support for supporting packages only at their edges during steam sterilization
US6050398A (en) 1998-11-25 2000-04-18 Novartis, Ag Contact lens storage container
USD435966S1 (en) 1999-01-29 2001-01-09 Johnson & Johnson Vision Care, Inc. Contact lens container
JP3461769B2 (ja) 1999-11-26 2003-10-27 株式会社ノエビア 皮膚外用剤
US6200594B1 (en) 1999-12-29 2001-03-13 Vital Dynamics, Inc. Breast-enhancing, herbal compositions and methods of using same
FR2811568B1 (fr) 2000-07-13 2003-01-17 Oreal Composition, notamment cosmetique, comprenant la dhea et/ou un precurseur ou derive de celle-ci, en association avec au moins un agent anti-glycation
FR2811567B1 (fr) 2000-07-13 2003-01-17 Oreal Composition, notamment cosmetique, comprenant la dhea et/ou un precurseur ou derive de celle-ci, en association avec au moins un inhibiteur de no-synthase
AU2001286578A1 (en) 2000-08-24 2002-03-04 Tim Ioannides Topical antioxidant having vitamin c and method of combination with topical agent by user
TWI332401B (en) 2001-08-21 2010-11-01 Shiseido Co Ltd Materials which are capable of enhancing laminin-5 producing ability in epidermal cell and the use thereof
JP2003137767A (ja) 2001-08-21 2003-05-14 Shiseido Co Ltd 表皮細胞におけるラミニン５産生促進剤
JP4918202B2 (ja) 2001-11-07 2012-04-18 株式会社ナリス化粧品 皮膚組成物
US20030113388A1 (en) 2001-12-13 2003-06-19 Dung Phan Methods of treatment for skin disorders using turmeric extract and a hydroxy acid
US7442391B2 (en) 2002-01-25 2008-10-28 Integrated Botanical Technologies, Llc Bioactive botanical cosmetic compositions and processes for their production
US20030165545A1 (en) 2002-01-30 2003-09-04 Allergan, Inc. Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
JP4542300B2 (ja) 2002-02-15 2010-09-08 株式会社ファンケル ヒアルロン酸蓄積促進剤
US20040146539A1 (en) 2003-01-24 2004-07-29 Gupta Shyam K. Topical Nutraceutical Compositions with Selective Body Slimming and Tone Firming Antiaging Benefits
US20040156873A1 (en) 2003-02-10 2004-08-12 Gupta Shyam K. Topically Bioavailable Acne and Rosacea Treatment Compositions
US20040161435A1 (en) 2003-02-14 2004-08-19 Gupta Shyam K. Skin Firming Anti-Aging Cosmetic Mask Compositions
JP2004262777A (ja) 2003-02-27 2004-09-24 Shiseido Co Ltd アセチル化ヒアルロン酸含有眼用医薬組成物
US20040223942A1 (en) 2003-03-06 2004-11-11 Kao Corporation Skin aging-preventing or improving agent
FR2853541B1 (fr) 2003-04-09 2008-07-04 Oreal Composition cosmetique stable contenant un glyceride d'acides gras, un alcool et un emulsionnant silicone particulier
JP4278473B2 (ja) 2003-08-22 2009-06-17 株式会社Ｎｒｌファーマ ドライアイを治療又は予防する新規医薬組成物
FR2860435B1 (fr) 2003-10-07 2008-08-01 Cosmetic Lab Concepts C L C Poudre d'eau a base de silice hydrophobe
JP3800611B2 (ja) 2003-10-31 2006-07-26 学校法人近畿大学 美白剤または色素沈着症改善剤
AU2003304547A1 (en) 2003-11-20 2005-06-08 Rubicon Research Private Limited Fiber rich fraction of trigonella foenum-graecum and its use as a pharmaceutcal excipient
ES2652603T3 (es) 2004-01-12 2018-02-05 Isp Investments Llc Composiciones bioactivas de plantas de Theacea y procedimientos para su producción y uso
US7452547B2 (en) 2004-03-31 2008-11-18 Johnson&Johnson Consumer Co., Inc. Product for treating the skin comprising a polyamine microcapsule wall and a skin lightening agent
JP2006008537A (ja) 2004-06-23 2006-01-12 Noevir Co Ltd 皮膚外用剤
JP2006063038A (ja) 2004-08-30 2006-03-09 Yukihiro Hirose 老化防止組成物およびそれを含有する化粧料ならびに飲食品
US20060110415A1 (en) 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
KR20060074038A (ko) 2004-12-27 2006-07-03 주식회사 나우코스 아토피성 피부염의 예방 효과를 가지는 조성물
US7205012B1 (en) 2005-02-25 2007-04-17 Hill Wendy L Scar reducing and massage emollient
JP2006273811A (ja) 2005-03-30 2006-10-12 Naris Cosmetics Co Ltd メイラード反応阻害剤
FR2889057B1 (fr) 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
WO2007030666A2 (en) 2005-09-07 2007-03-15 Herbal Intervention Corporation Medicated skin care preparation for promoting wound healing
ITMI20052036A1 (it) 2005-10-26 2007-04-27 Professional Dietetics Srl Composizioni farmaceutiche oftalmiche a base di amminoacidi e sodio ialuronato
KR100870104B1 (ko) 2005-11-28 2008-11-26 주식회사 머젠스 안구건조증 치료 및 예방용 조성물
AU2007217003B2 (en) 2006-02-21 2013-04-04 Isp Investments Inc. Parthenolide free bioactive ingredients from feverfew (Tanacetum parthenium) and processes for their production
FR2904549B1 (fr) 2006-08-03 2012-12-14 Sederma Sa Composition comprenant de la sarsasapogenine
EA018425B1 (ru) 2007-04-13 2013-07-30 В-БАЙОТЕК ХОЛДИНГ ЭйПиЭс Фармацевтический, дезинфицирующий или консервирующий экстракт пажитника сенного (trigonella foenum-graecum), способ его получения и применение экстракта
JP2009013128A (ja) 2007-07-06 2009-01-22 Sosin:Kk 皮膚外用剤及び口腔用組成物
CN101336869A (zh) 2007-08-09 2009-01-07 吴志刚 一种天然花瓣面膜及其制备方法
CN101411679A (zh) 2007-09-20 2009-04-22 吴志刚 含花瓣成份的化学用品及其制备方法
FR2927252B1 (fr) 2008-02-12 2010-04-23 Oreal Emulsion huile-dans-eau contenant un polyere amphiphile
US20090241242A1 (en) 2008-03-31 2009-10-01 Heidi Beatty Facial mask
US9486418B2 (en) 2008-04-08 2016-11-08 Dynamis Pharmaceuticals, Inc. Method for treating or preventing dry eye disorders using alkylamino-polyhydroxyalkanes
CN101376016B (zh) 2008-10-06 2010-10-13 梁竹 一种治疗高脂血症的中药制备方法
CN102238949A (zh) 2008-10-09 2011-11-09 拉姆斯科股份有限公司 治疗干眼综合征的组合物和方法
JP4960948B2 (ja) 2008-10-31 2012-06-27 共栄化学工業株式会社 植物抽出エキスの製造方法及び化粧料
KR20110116018A (ko) 2008-12-24 2011-10-24 에코바이오틱스 리미티드 운향 종들의 식물 추출물 및 이의 용도
WO2010085572A1 (en) 2009-01-23 2010-07-29 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with azithromycin
GB0902040D0 (en) 2009-02-06 2009-03-11 Seeds Lp Composition for treatment of skin
WO2010111745A1 (en) 2009-04-02 2010-10-07 Jurlique International Pty Ltd Compositions and methods for increasing vitamin c uptake into cells and methods for retarding skin ageing, lightening skin and modulating hair colour
US9480645B2 (en) 2009-06-02 2016-11-01 Abbott Medical Optics Inc. Omega-3 oil containing ophthalmic emulsions
US20100305046A1 (en) 2009-06-02 2010-12-02 Abbott Medical Optics Inc. Stable cyclosporine containing ophthalmic emulsion for treating dry eyes
RU2589837C2 (ru) 2009-06-05 2016-07-10 Аллерган, Инк. Искусственные слезы и терапевтические применения
US20120003296A1 (en) 2010-07-01 2012-01-05 Shantha Totada R New methods of treating dry eye syndrome
US9364414B2 (en) 2011-02-01 2016-06-14 Isp Investments Inc. Method to protect skin from ultraviolet radiation using novel peptides involved in the improvement of microparasol organization in keratinocytes
US9138446B2 (en) 2011-06-08 2015-09-22 Scott Alan Weisenfluh EMU oil in combination with other active ingredients for treating skin imperfections
US20130195925A1 (en) 2011-11-03 2013-08-01 Vaskin, Llc Anti aging application and method for treating aging
MX2011013407A (es) 2011-12-13 2013-06-14 Pharmacos Exakta S A De C V Solucion oftálmica nanotecnológica a base de extractos herbolarios a partir de manzanilla y caléndula.
ES2443816B1 (es) 2012-03-22 2014-12-09 Psoriapiel Salud, S.L. Composición para la prevención y/o el tratamiento de la dermatosis y procedimiento de obtención del mismo
US9814659B2 (en) 2012-04-02 2017-11-14 Johnson & Johnson Consumer Inc. Methods of lightening the skin
WO2013171764A2 (en) 2012-04-30 2013-11-21 Rubicon Research Private Limited Ophthalmic formulations
FR2996136B1 (fr) 2012-09-28 2015-01-02 Inneov Lab Utilisation d'une association d'au moins un acide gras polyinsature et d'au moins un carotenoide pour ameliorer la qualite des ongles.
CN103142968B (zh) 2013-03-22 2014-02-05 顾克斌 一种治疗干眼症的药剂
CN103505389B (zh) 2013-07-31 2015-04-01 康向群 含有金盏花花瓣的化妆水及其制备方法
WO2015099019A1 (ja) 2013-12-25 2015-07-02 わかもと製薬株式会社 ドライアイ治療用点眼剤
CN104042540A (zh) 2014-05-31 2014-09-17 青岛博泓海洋生物技术有限公司 一种祛斑补水化妆水
KR101584742B1 (ko) 2014-07-16 2016-02-02 천유화장품(주) 피부노화개선용 화장료조성물
FR3025424B1 (fr) 2014-09-05 2016-12-23 Soc Ind Limousine D'application Biologique Principe actif obtenu a partir de calendula officinalis et utilisation dans la prevention et le traitement de manifestations cutanees dues a un dereglement de l'epigenome dans les cellules de la peau
WO2016096344A1 (en) 2014-12-15 2016-06-23 Unilever Plc Compositions for providing improved sunscreen protection
WO2016141098A1 (en) 2015-03-05 2016-09-09 Allergan, Inc. Self-emulsifying drug delivery system (sedds) for ophthalmic drug delivery
KR101754220B1 (ko) 2015-03-11 2017-07-06 (주)시크릿허브코리아 천연 생약초 추출물을 포함하는 피부 노화, 아토피 개선 및 피부 미백용 조성물 및 이의 제조방법
KR20160116733A (ko) 2015-03-31 2016-10-10 유한회사 천향 카렌듈라 인퓨즈드 오일을 함유하는 비누 및 이의 제조방법
ITUB20152286A1 (it) 2015-07-17 2017-01-17 Harven S A S Composizione anti herpes
KR20170012810A (ko) 2015-07-24 2017-02-03 (주)뷰티화장품 천연꽃잎을 포함하는 하이드로겔 팩
US9925137B2 (en) 2015-08-19 2018-03-27 Maple Mountain Group, Inc. Skin rejuvenation and defense system
US10010572B2 (en) 2015-08-28 2018-07-03 Winston C. V. Parris Composition for musculoskeletal pain
CN108135926A (zh) 2015-09-24 2018-06-08 基质生物研究所 高弹性透明质酸组合物及其使用方法
CN105411960A (zh) 2015-12-30 2016-03-23 广州环亚化妆品科技有限公司 一种具有抑制痤疮功效的面膜及其制备方法
CN105997789A (zh) 2016-06-21 2016-10-12 江苏奇力康皮肤药业有限公司 一种含金盏花提取物的爽肤水
CN106176275B (zh) 2016-08-31 2017-09-15 广东芭薇生物科技股份有限公司 一种基于端粒酶延缓肌肤衰老症候的护肤品
US20190008905A1 (en) 2017-07-07 2019-01-10 Noori AL-WAILI Compositions for management of wounds, skin diseases, dehydration, chronic diseases, and respiratory diseases
CN111372556A (zh) 2017-09-28 2020-07-03 强生消费者公司 化妆品组合物和治疗皮肤的方法
SG11202003229RA (en) 2017-10-11 2020-05-28 Illustris Pharmaceuticals Inc Methods and compositions for topical delivery
WO2018154145A2 (en) 2018-03-29 2018-08-30 Symrise Ag Compounds for skin improvement / treatment
CN108852985A (zh) 2018-06-11 2018-11-23 连云港鸿凝生物科技有限公司 一种保湿无刺激防腐面膜液及其制备方法
CN115671090A (zh) 2018-07-27 2023-02-03 强生外科视力公司 用于治疗眼睛的组合物和方法
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
KR20210038636A (ko) 2018-07-27 2021-04-07 존슨 앤드 존슨 서지컬 비전, 인코포레이티드 눈 치료용 조성물 및 방법
US20200030226A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Consumer Inc. Botanical and bacterial extracts displaying retinol-like activity
CN109833267A (zh) 2019-04-18 2019-06-04 中山市怡口康科技有限公司 一种金盏花逆龄精华酿组合物

Also Published As

Publication number Publication date
US20210145916A1 (en) 2021-05-20
BR102020023578A2 (pt) 2021-05-25
AU2022246418B2 (en) 2023-12-07
AU2022246418A1 (en) 2022-11-03
ZA202007183B (en) 2023-01-25
US11969454B2 (en) 2024-04-30
AU2020273325A1 (en) 2021-06-03
KR20210061299A (ko) 2021-05-27
JP2021080254A (ja) 2021-05-27
CA3099504A1 (en) 2021-05-19

Similar Documents

Publication Publication Date Title
BR112018004620A2 (pt) moduladores da expressão de kras
BR112019006876A2 (pt) anticorpos e composições anti-lag-3
BR112023021068A2 (pt) Compostos, composições e métodos para tratar câncer
BR112019001607A2 (pt) inibidores macrocíclicos de quinases
BR112018008746A2 (pt) composições e métodos para a inibição de atividade de arginase
BR112018000542A2 (pt) composições de irna de transtirretina (ttr) e métodos de uso das mesmas para o tratamento ou prevenção de doenças associadas à ttr
BR112021006392A2 (pt) moduladores da alfa-1 antitripsina
BR112017005517A2 (pt) anticorpos antiage para o tratamento de inflama-ção e de transtornos autoimunes
BR112017026739A2 (pt) compostos para uso no tratamento de distúrbios neuromusculares
BR112016022593A2 (pt) composições e métodos para modular a expressão do fator b do complemento
BR112018008601A2 (pt) composições compreendendo o canabidiol e segundos agentes terapêuticos para o tratamento de câncer
WO2020021477A3 (en) Compositions and methods for treating the eye
NI202100018A (es) Moduladores de la expresión de pnpla3
BR112019021867A2 (pt) Compostos de fenil-2-hidroxi-acetilamino-2-metil-fenil
BR112021019262A2 (pt) Uso de ciclo-his-pro (chp) para prevenir, atenuar ou tratar fibrose
BR112018075135A2 (pt) combinações farmacêuticas para tratar câncer
BR112017009545A2 (pt) composição antibacteriana, método para a preparação de uma composição, bacteriófago, ácido nucleico isolado, polipeptídeo isolado, e uso de um bacteriófago, ácido nucleico ou polipeptídeo
CR20190471A (es) Moduladores de la expresión de pcsk9
BR112016027043A8 (pt) combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer
BR112018008911A2 (pt) composições compreendendo vetores lentivirais que expressam il-12 e métodos de uso das mesmas
BR112019020414A2 (pt) composições e métodos para detectar e tratar câncer de próstata usando moléculas de ligação à progastrina
BR102020023578A8 (pt) Composições e métodos para tratamento do olho
BR112018012927A2 (pt) reguladores cftr e métodos de uso dos mesmos
NI202000085A (es) Moduladores de la expresión de apol1
WO2020021480A3 (en) Compositions and methods for treating the eye

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: JOHNSON AND JOHNSON SURGICAL VISION, INC. (US)